MediPal saw the highest growth of 0.24% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.24% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of MediPal’s patent filings and grants. Buy the databook here.
MediPal has been focused on protecting inventions in United States(US) with one publication in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 100% of filings. The United States(US) patent Office are among the top ten patent offices where MediPal is filings its patents..
Kao could be the strongest competitor for MediPal
Patents related to smart supply chain and supply chain management lead MediPal's portfolio
MediPal has the highest number of patents in smart supply chain followed by, supply chain management and supply chain. For smart supply chain, nearly 33% of patents were filed and no patents were granted in Q2 2024.
Packaging related patents lead MediPal portfolio followed by it services, and 3pl/4pl
MediPal has highest number of patents in packaging followed by it services, 3pl/4pl.
For comprehensive analysis of MediPal's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.